PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
54.18%
Revenue growth above 1.5x 5715.T's 0.12%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
46.39%
Gross profit growth above 1.5x 5715.T's 11.73%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
84.64%
Positive EBIT growth while 5715.T is negative. John Neff might see a substantial edge in operational management.
62.55%
Operating income growth at 50-75% of 5715.T's 122.32%. Martin Whitman would doubt the firm’s ability to compete efficiently.
70.19%
Positive net income growth while 5715.T is negative. John Neff might see a big relative performance advantage.
70.18%
Positive EPS growth while 5715.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
70.18%
Positive diluted EPS growth while 5715.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.46%
10Y revenue/share CAGR above 1.5x 5715.T's 2.81%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
1.20%
5Y revenue/share CAGR under 50% of 5715.T's 15.08%. Michael Burry would suspect a significant competitive gap or product weakness.
-10.83%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
100.00%
10Y OCF/share CAGR in line with 5715.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-214.80%
Negative 10Y net income/share CAGR while 5715.T is at 116.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-184.42%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-167.39%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
363.18%
10Y equity/share CAGR above 1.5x 5715.T's 86.48%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
45.89%
5Y equity/share CAGR above 1.5x 5715.T's 25.49%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
13.94%
3Y equity/share CAGR above 1.5x 5715.T's 2.00%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.03%
Firm’s AR is declining while 5715.T shows 8.94%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.92%
We show growth while 5715.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
4.17%
Asset growth above 1.5x 5715.T's 0.36%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.05%
We have a declining book value while 5715.T shows 1.81%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.90%
We have some new debt while 5715.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
12.70%
R&D growth of 12.70% while 5715.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
3.92%
We expand SG&A while 5715.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.